Expected Weight Loss Results at 5mg Tirzepatide Clinical trial data from SURMOUNT-1 showed that patients using tirzepatide 5mg lost an average of 57% of their starting body weight over 12 weeks, with some reaching 10% weight loss by week 12
Both options contain identical tirzepatide molecules
In one study involving 120 endometriosis patients, NAC supplementation for three weeks resulted in an 86.5% pregnancy rate among those desiring conception
Weight loss with Tirzepatide is gradual, and continued usealongside healthy lifestyle habitsis necessary to maintain your progress
[1] It is also important to consider that some patients may have co-existing conditions such as hypothyroidism, anaemia, depression, or sleep apnoeathat independently cause fatigue and may be unmasked or exacerbated during treatment
The timelines reported below come from published clinical trials and self-reported community sources